Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-EDB antibodies and antibody-drug conjugates

Anti-EDB antibodies and antibody-drug conjugates

US Patent 11833216 · Granted Dec 5, 2023

Estimated economic value: $849,409,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Constrained conditionally activated binding proteins2025
CDCP1 antibodies and antibody drug conjugates2025
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-2024
Calicheamicin derivatives and antibody drug conjugates thereof2024
Therapeutic antibodies and their uses2023
Constrained conditionally activated binding proteins2023
Constrained conditionally activated binding proteins2023
Single domain antigen binding domains that bind human Trop22023
Constrained conditionally activated binding proteins2022
Bifunctional cytotoxic agents containing the CTI pharmacophore2022
Engineered antibody constant regions for site-specific conjugation and methods a2021
Bifunctional cytotoxic agents containing the CTI pharmacophore2020